Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in LITS — Lite Strategy, Inc.

CIK 1595888 NEW YORK, NY
Back to LITS Full portfolio

Position in LITS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$177,216
+$110,811 QoQ
Shares Held
192,627
+236.5% QoQ
Ownership
0.633%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 35 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LITS Over Time

Shares Held

Position Value (USD)

Derivatives in LITS

reported options exposure · as of Jun 30, 2026
CallValue
$28,612
CallShares
31,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,373,713,627 across 292 Biotechnology names. LITS ranks #175 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in LITS

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,612 31,100
2026-06-30 $177,216 192,627
2026-03-31 $66,405 57,246
2026-03-31 $26,448 22,800
2025-12-31 $199,903 151,443
2025-09-30 $175,027 72,326
2025-09-30 $61,710 25,500
2025-09-30 $167,464 69,200